What Is Ketorolac?
Ketorolac is a prescription-strength NSAID with 5x the analgesic potency of diclofenac. Originally used IV in hospitals, it's now available as a topical formulation — applied directly to the skin for targeted pain relief.
Ketorolac tromethamine is a prescription nonsteroidal anti-inflammatory drug (NSAID) with 5x the analgesic potency of diclofenac and 2x the anti-inflammatory potency. Originally developed for IV and IM use in hospitals, topical ketorolac delivers this same potent medication directly through the skin — concentrating at the pain site with minimal systemic exposure.
Ketorolac at a Glance
NSAID (nonsteroidal anti-inflammatory drug). Part of the pyrrolizine carboxylic acid derivative family.
COX-1 and COX-2 inhibitor — blocks prostaglandin synthesis at the site of inflammation, reducing pain, swelling, and sensitization.
IV (intravenous), IM (intramuscular injection), oral tablet, ophthalmic (eye drops), and topical (compounded gel/cream).
Yes — all forms of ketorolac require a prescription. A physician evaluates your health history before prescribing.
FDA-approved for injectable (IV/IM) and oral forms. Topical ketorolac is compounded by licensed US pharmacies under physician prescription.
Toradol (injectable/oral), Acular/Acuvail (ophthalmic). Topical formulations are compounded — not mass-manufactured brand products.
How Ketorolac Works
Ketorolac blocks the enzymes that produce pain and inflammation at the source. When applied topically, it concentrates in local tissue instead of circulating through your entire body.
When tissue is damaged or chronically irritated — from arthritis, TMJ, muscle strain, or repetitive stress — your body produces prostaglandins. These chemical messengers trigger inflammation, pain signaling, and swelling at the affected site.
Ketorolac blocks both COX-1 and COX-2 enzymes — the proteins responsible for producing prostaglandins. By inhibiting these enzymes, ketorolac stops the inflammatory cascade at its biochemical origin. It does this with significantly more potency than most other NSAIDs.
With prostaglandin production blocked, inflammation decreases. Pain signaling diminishes. Swelling subsides. The sensitization cycle that keeps you hurting — where inflammation makes nerves more sensitive, which amplifies pain, which triggers more inflammation — gets interrupted.
When applied topically, ketorolac penetrates the skin and concentrates in the underlying muscle and joint tissue. It blocks inflammation at the source without significant systemic absorption. Studies show 5-17x less drug enters the bloodstream compared to oral administration — meaning the medication works where you put it, not everywhere else.
Topical Ketorolac vs. Oral Ketorolac
Same active ingredient. Fundamentally different delivery. Topical ketorolac concentrates medication at the application site while oral ketorolac distributes the drug throughout your entire body. The clinical implications are significant — especially for long-term use and localized pain conditions.
Applied to the skin directly over the pain site. Penetrates into local tissue and concentrates where inflammation is occurring.
- High tissue concentration at application site
- 5-17x lower systemic absorption
- GI side effects equivalent to placebo
- No first-pass liver metabolism
- Can be used for extended periods (physician-supervised)
- Self-applied daily at home
Swallowed as a pill. Absorbed through the GI tract, processed by the liver, distributed through the bloodstream to the entire body.
- Limited to 5 days maximum (FDA guideline)
- Full systemic drug exposure
- Significant GI bleeding risk
- Kidney function impact with repeated use
- Cardiovascular risk with prolonged use
- Treats entire body for localized pain
How Ketorolac Compares to Other NSAIDs
Not all NSAIDs are created equal. Ketorolac stands apart from the field in analgesic potency — the reason hospitals use it for post-surgical pain.
| NSAID | Analgesic Potency | Anti-inflammatory Potency | Availability | Common Form |
|---|---|---|---|---|
| Ketorolac | 5x diclofenac | 2x diclofenac | Prescription only | Topical gel (compounded), IV, oral |
| Diclofenac | 1x (reference) | 1x (reference) | OTC (1%) or Rx (higher %) | Voltaren gel, patches |
| Ketoprofen | ~1.5x diclofenac | ~1.5x diclofenac | Prescription | Topical gel (compounded) |
| Naproxen | ~1x diclofenac | ~1x diclofenac | OTC / Rx | Oral tablets (Aleve) |
| Ibuprofen | ~0.5x diclofenac | ~0.5x diclofenac | OTC | Oral tablets, topical gel |
Clinical Evidence for Topical Ketorolac
Peer-reviewed research and clinical data supporting topical NSAID delivery. Not marketing claims — published science.
Clinical studies of topical ketorolac demonstrated 55.8% pain reduction within 15 days of consistent use.
Topical NSAIDs deliver medication to the site with 5-17x less drug entering the bloodstream than oral.
Topical NSAIDs showed GI toxicity equivalent to placebo. Your stomach doesn't process the medication.
The gold-standard Cochrane systematic review compared topical vs. oral NSAIDs across 1,735 participants for musculoskeletal conditions. Result: 55% clinical success rate for topical vs. 54% for oral — statistically equivalent efficacy. Topical showed GI adverse events equivalent to placebo while oral carried significant GI risk.
A 2019 meta-analysis in Drugs & Aging confirmed that topical NSAIDs show gastrointestinal toxicity equivalent to placebo. Systemic absorption is 5-17x lower than oral NSAIDs, meaning minimal exposure to kidneys, liver, and cardiovascular system. This safety profile is what makes topical delivery viable for long-term pain management.
Clinical outcome data from Precision Compounding Pharmacy demonstrated 55.8% pain reduction within 15 days of consistent topical ketorolac use. Patients reported significant improvement in both pain intensity and functional capacity without the gastrointestinal complications associated with oral NSAID therapy.
The topical ketorolac formulation used in Ketro RX Pain Gel was originally developed for professional athletes. Precision Compounding Pharmacy created the formulation for the Boston Red Sox training staff — professional athletes who needed potent anti-inflammatory relief without the systemic side effects that would affect performance. That same formulation is now available direct to patients.
Topical Ketorolac: Not Your Average Pain Cream
Topical ketorolac isn't Voltaren, Biofreeze, or any mass-market product on the pharmacy shelf. It's a fundamentally different category of topical pain relief.
Ketorolac is the NSAID hospitals use for post-surgical pain, kidney stones, and acute injuries. It has 5x the analgesic potency of diclofenac (Voltaren) and approximately 10x the potency of ibuprofen. Topical formulation delivers this same potency directly to the pain site.
Every order is individually prepared by Precision Compounding Pharmacy — a licensed US compounding facility. Not mass-manufactured. Not sitting on a warehouse shelf. Your prescription is compounded specifically for you, then shipped directly.
When you swallow a ketorolac pill, the drug distributes throughout your entire body — only a fraction reaches the specific area that hurts. Topical application concentrates medication in the tissue directly beneath the skin. The result: higher drug concentration at the pain site with 5-17x less drug circulating systemically.
Oral NSAIDs pass through the stomach and liver before reaching the bloodstream — the "first-pass effect." This exposes the GI tract to the drug and is a primary cause of NSAID-related ulcers and bleeding. Topical ketorolac bypasses the GI system entirely. It absorbs through the skin, avoiding the stomach, liver, and the associated risks.
What Topical Ketorolac Treats
Topical ketorolac is used for localized pain and inflammation conditions — anywhere the affected tissue is close enough to the skin surface for topical penetration to reach therapeutic concentrations.
The masseter muscle sits directly under the skin — making the jaw one of the most responsive locations for topical delivery. Topical NSAIDs matched oral for TMJ with zero systemic side effects.
The ACR recommends topical NSAIDs as first-line for knee and hand osteoarthritis over oral. Joints close to the skin surface respond well to topical delivery.
Lateral and medial epicondylitis — inflammation of the tendons at the elbow. Superficial location makes it accessible for topical anti-inflammatory penetration.
Muscle-related back pain and superficial inflammation. Topical delivery works best for pain sources close to the skin — paraspinal muscles, lower back tension, and muscle spasm.
Desk work, stress, and poor posture create chronic tension in the trapezius and cervical muscles. These superficial muscles respond well to topical anti-inflammatory treatment.
Ketorolac has a long history in post-surgical pain management (IV/IM). Topical application can address localized post-surgical inflammation at incision sites and surrounding tissue.
Many tension headaches originate from muscle tension in the jaw, neck, and temples. Topical anti-inflammatory applied to these trigger points addresses the source directly.
For ongoing pain conditions that require daily management, topical ketorolac offers potent anti-inflammatory relief without the GI and systemic risks of daily oral NSAID use.
Topical Ketorolac Safety
Topical delivery fundamentally changes the safety profile compared to oral ketorolac. Minimal systemic exposure means fewer systemic risks.
- Most common side effect: mild skin irritation at application site (10-15% of patients)
- Systemic absorption 5-17x lower than oral NSAIDs
- GI adverse events equivalent to placebo in meta-analysis
- No GI first-pass metabolism — bypasses the stomach entirely
- Minimal kidney and cardiovascular exposure compared to oral
- Prescription includes physician review of your health history
- Not recommended for patients with known NSAID allergies
- Not recommended for patients with active GI bleeding
- Not recommended for patients with severe kidney disease
- Use caution with blood thinners — consult your physician
- Avoid applying to broken skin or open wounds
- Prescription required — a doctor reviews your health history, medications, and kidney function before prescribing
Ketro RX Pain Gel
Prescription-strength topical ketorolac. Originally formulated for the Boston Red Sox, now available direct to patients.
Ketro RX Pain Gel uses prescription-strength ketorolac in a topical formulation. Originally formulated for the Boston Red Sox, now available direct to patients. Applied directly to the pain site — the medication absorbs right where the inflammation is. No GI side effects, minimal systemic exposure. Compounded per order by a US-licensed pharmacy.
- Prescription-strength ketorolac (5x potency of diclofenac)
- 55.8% pain reduction by day 15 in clinical studies
- Topical delivery — 5-17x lower systemic absorption
- Compounded per order by Precision Compounding Pharmacy
- Online physician consultation included
- Originally formulated for the Boston Red Sox
For daily muscle tension and soreness. Topical magnesium supports muscle relaxation and recovery. Pairs with RX Pain Gel for a complete approach — prescription-strength anti-inflammatory for flares, daily magnesium for maintenance.
- Premium transdermal magnesium
- Fast-absorbing, non-greasy
- No prescription needed
Ketorolac FAQ
Sources & Citations
- Derry S, Wiffen PJ, Kalso EA, et al. Topical analgesics for acute and chronic pain in adults — an overview of Cochrane Reviews. Cochrane Database of Systematic Reviews. 2017. doi:10.1002/14651858.CD008609.pub2
- Derry S, Conaghan P, Da Silva JAP, et al. Topical NSAIDs for chronic musculoskeletal pain in adults. Cochrane Database of Systematic Reviews. 2016. doi:10.1002/14651858.CD007400.pub4
- Zeng C, Wei J, Persson MSM, et al. Relative efficacy and safety of topical non-steroidal anti-inflammatory drugs for osteoarthritis: a systematic review and network meta-analysis. Drugs & Aging. 2019;36(6):581-590. doi:10.1007/s40266-019-00716-4
- Kienzler JL, Gold M, Nollevaux F. Systemic bioavailability of topical diclofenac sodium gel 1% versus oral diclofenac sodium in healthy volunteers. J Clin Pharmacol. 2010;50(1):50-61. doi:10.1002/jcph.806
- Honvo G, Leclercq V, Geerinck A, et al. Safety of topical non-steroidal anti-inflammatory drugs in osteoarthritis: outcomes of a systematic review and meta-analysis. Drugs & Aging. 2019;36(Suppl 1):45-64. doi:10.1007/s40266-019-00661-0
- Kolasinski SL, Neogi T, Hochberg MC, et al. 2019 American College of Rheumatology/Arthritis Foundation guideline for the management of osteoarthritis of the hand, hip, and knee. Arthritis & Rheumatology. 2020;72(2):220-233. doi:10.1002/art.41142
- Toradol (ketorolac tromethamine) prescribing information. Roche Laboratories Inc. Revised 2012.
- Mehlisch DR, Frakes LA. A controlled comparative evaluation of intravenous ketorolac, butorphanol, and diazepam for treatment of post-oral-surgery pain. PMID 15871609. PubMed
- Precision Compounding Pharmacy. Clinical Outcomes Report: Topical Ketorolac Formulation. 2025. Data on file.
Continue Reading
The masseter sits right under the skin — making TMJ one of the most responsive conditions for topical ketorolac delivery.
The ACR recommends topical NSAIDs as first-line for knee and hand osteoarthritis. Same efficacy as oral, fraction of the risk.
Browse all conditions treated with topical pain relief — from back pain and neck tension to headaches and post-workout soreness.
Get Prescription-Strength Topical Ketorolac
Hospital-grade potency. Applied directly to the pain site. Compounded per order by a US-licensed pharmacy.
This content is for informational purposes only and does not constitute medical advice. Consult a healthcare provider before starting any new treatment. Individual results may vary. Ketro RX Pain Gel requires a prescription — a licensed physician reviews your health information before prescribing. Ketorolac potency comparisons are based on published pharmacological data comparing relative analgesic and anti-inflammatory activity of NSAIDs. Clinical data referenced from published peer-reviewed studies and manufacturer outcomes reports.